Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.010 Biomarker phenotype BEFREE These results identify a novel mechanistic link between mTOR and orexin in the hypothalamus related to sleep dysfunction and suggest a targeted therapeutic approach to sleep disorders in TSC. 31605778 2020
Entrez Id: 4397
Gene Symbol: MS
MS
0.010 Biomarker phenotype BEFREE Our aim was to investigate the impact of the clinical features of the first clinical episode on cognitive disability and sleep dysfunction in MS. 31432354 2020
Entrez Id: 7514
Gene Symbol: XPO1
XPO1
0.010 Biomarker phenotype BEFREE A gradual decrease in sleep disturbance was observed in Exp 2 after the 2nd CTx cycle, whereas Exp 1 experienced a steady increase in the symptom. 31129760 2020
Entrez Id: 10137
Gene Symbol: RBM12
RBM12
0.010 GeneticVariation phenotype BEFREE Monthly variation of hot flashes, night sweats, and trouble sleeping: effect of season and proximity to the Final Menstrual Period (FMP) in the SWAN Menstrual Calendar substudy. 31567864 2020
Entrez Id: 1434
Gene Symbol: CSE1L
CSE1L
0.010 Biomarker phenotype BEFREE A gradual decrease in sleep disturbance was observed in Exp 2 after the 2nd CTx cycle, whereas Exp 1 experienced a steady increase in the symptom. 31129760 2020
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.010 AlteredExpression phenotype BEFREE Here, we characterized a mouse model of sleep disorders in TSC and investigated mechanisms of sleep dysfunction in this conditional knockout model involving inactivation of the Tsc1 gene in neurons and astrocytes (Tsc1<sup>GFAP</sup>CKO mice). 31605778 2020
Entrez Id: 907
Gene Symbol: CCT
CCT
0.010 Biomarker phenotype BEFREE We assessed sleep disturbance repeatedly in: a) 523 adults with recurrent MDD who consented to 12-14 weeks of acute-phase cognitive therapy (A-CT) and b) 241 A-CT responders at elevated risk for depression relapse/recurrence who were randomized to 8 months of continuation-phase treatment (CCT vs. fluoxetine vs. matched pill placebo) and followed protocol-treatment-free for 24 months. 31735410 2020
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 PosttranslationalModification phenotype BEFREE There was no association between sleep disturbances and AVPR1a or AVPR1b methylation, or between sleep disturbances and any of the AVP methylation for the LowPR group. 31132568 2019
Entrez Id: 1446
Gene Symbol: CSN1S1
CSN1S1
0.010 Biomarker phenotype BEFREE A Double-Blind, Randomized, Placebo-Controlled Crossover Clinical Study of the Effects of Alpha-s1 Casein Hydrolysate on Sleep Disturbance. 31252661 2019
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.010 Biomarker phenotype BEFREE Individuals who sleep >7 hours/night with no trouble sleeping are 40% less likely to have severe periodontal disease (odds ratio [OR] = 0.6, P < 0.05), adjusting for age, sex, smoking status, FPL, education level, and dental visit. 31749207 2019
Entrez Id: 9365
Gene Symbol: KL
KL
0.010 GeneticVariation phenotype BEFREE In gene by environment analyses, two KL variants (rs9315202 and rs9563121) interacted with PTSD severity (peak corrected p = 0.044) and sleep disturbance (peak corrected p = 0.034) to predict advanced epigenetic age. 30872092 2019
Entrez Id: 6046
Gene Symbol: BRD2
BRD2
0.010 AlteredExpression phenotype BEFREE Recent studies have found altered levels of FSH, LH, and prolactin with sleep disturbance or circadian dysrhythmia. 31644470 2019
Entrez Id: 10261
Gene Symbol: IGSF6
IGSF6
0.010 Biomarker phenotype BEFREE This study showed that DORA-12 can affect the sleep disturbance that is associated with a history of adolescent ethanol exposure and also has several other sleep-promoting effects that are equivalent in both ethanol and control rats. 31659377 2019
Entrez Id: 7369
Gene Symbol: UMOD
UMOD
0.010 Biomarker phenotype BEFREE To investigate the effects and mechanisms of l-THP on sleep disturbance in a neuropathic pain-like condition. 31172225 2019
Entrez Id: 552
Gene Symbol: AVPR1A
AVPR1A
0.010 Biomarker phenotype BEFREE There was no association between sleep disturbances and AVPR1a or AVPR1b methylation, or between sleep disturbances and any of the AVP methylation for the LowPR group. 31132568 2019
Entrez Id: 100038247
Gene Symbol: PTLS
PTLS
0.010 Biomarker phenotype BEFREE Subjects with PTLS have mild sleep disturbances such as sleep apnea with no melatonin abnormalities described. 31342617 2019
Entrez Id: 11168
Gene Symbol: PSIP1
PSIP1
0.010 AlteredExpression phenotype BEFREE Within the FM group, patients with arthralgia had higher anti-DFS70 antibody values compared to those without arthralgia (p = 0.024); antibody levels were also higher in patients with sleep disturbances relative to those without sleep issues (p = 0.024). 29166758 2019
Entrez Id: 217
Gene Symbol: ALDH2
ALDH2
0.010 Biomarker phenotype BEFREE Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson's Disease. 31831791 2019
Entrez Id: 2736
Gene Symbol: GLI2
GLI2
0.010 Biomarker phenotype BEFREE To investigate the effects and mechanisms of l-THP on sleep disturbance in a neuropathic pain-like condition. 31172225 2019
Entrez Id: 7849
Gene Symbol: PAX8
PAX8
0.010 PosttranslationalModification phenotype BEFREE The accumulative effect of blast showed increased methylation of PAX8 antisense transcript with coordinated repression of gene expression, which has been associated with sleep disturbance. 31621494 2019
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.010 GeneticVariation phenotype BEFREE Then, we analyzed associations of IGF-1 variants with neuropsychiatric symptoms after mTBI, including anxiety, depression, dizziness, and sleep disturbances. 31787098 2019
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.010 Biomarker phenotype BEFREE Recent studies have found altered levels of FSH, LH, and prolactin with sleep disturbance or circadian dysrhythmia. 31644470 2019
Entrez Id: 54
Gene Symbol: ACP5
ACP5
0.010 Biomarker phenotype BEFREE In symptom distress, the changes only in fatigue and sleep disturbance were positively associated with the trend in TRACP5a. 30658113 2019
Entrez Id: 79058
Gene Symbol: ASPSCR1
ASPSCR1
0.010 AlteredExpression phenotype BEFREE Higher GDS-scores and poorer TUG were independently associated with an overall level of poorer PF and global QoL throughout follow-up, as were more pain, dyspnea, and appetite loss, and sleep disturbance. 31444088 2019
Entrez Id: 4054
Gene Symbol: LTBP3
LTBP3
0.010 Biomarker phenotype BEFREE The Depression, Anxiety and Stress Scale (DASS-21) and The Pittsburgh Sleep Quality Index (PSQI) were used to measure depression, anxiety, stress, and sleep dysfunction. 30300870 2018